Severe Acute Respiratory Syndrome: all 386 studies
Page 2 of 4. Open to participants first (14), then studies with results posted, then the rest; newest registration first within each.
- Lung Ultrasound Findings in Patients With COVID-19 in a UK EDCompletedNCT05065827
- Performance of a Remote Monitoring Program for Patients Diagnosed With COVID-19CompletedNCT05063812
- Lung Ultrasound Changes in Covid 19 Patients Discharged From HospitalCompletedNCT05062603
- Protocol Design for Evaluating the Immunity of Bivalve Fluids From Anodonta Cygnea in SARS and COVID-19Status unknownNCT05054075Phase 2
- Co-Sér: Serological Analysis and Viral Neutralization in People With a Documented COVID-19 InfectionCompletedNCT05000307Not applicable
- Practice Variation on Antithrombotics in COVID-19CompletedNCT04998799
- Efficacy, Immunogenicity and Safety of BBIBP-CorV Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.Status unknownNCT04984408Phase 3
- Colloidal Silver, Treatment of COVID-19Status unknownNCT04978025Not applicable
- Muscle Weakness in COVID-19 PatientsCompletedNCT04959773
- COVID-19 Recovery Study: Symptoms and Biomarkers of Long COVID-19 in People Living With and Without HIVCompletedNCT04958889
- Human Epidemiology of Newly Identified ArbovirusesStatus unknownNCT04954352
- Studies to Determine Whether Oxygen Sensing is Impaired in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected PatientsCompletedNCT04954157Not applicable
- Characteristics of Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection (COVID-19)Status unknownNCT04948242
- Characterization Immunology, Biochemical and Lung Microbiome, Correlated With the Ventilation Associated Pneumonia (VAP)Status unknownNCT04944823
- Study to Assess the Efficacy and Safety of Favipiravir-HUTerminatedNCT04940871Phase 2
- Pulmonary Inflammation in COVID-19 ARDSStatus unknownNCT04935450
- Personalized Dietary Advice 3 Months After Discharge From Hospitalization in Geriatrics: Effect on Nutritional Status According to Coronavirus Disease 2019 (COVID-19) Status (Positive or Negative) During HospitalizationCompletedNCT04933929Not applicable
- Reactogenicity, Safety and Immunogenicity of QazCoVac-P COVID-19 VaccineCompletedNCT04930003Phase 1/2
- Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 InfectionStatus unknownNCT04920838Phase 2/3
- Inspiratory Muscle Trainer and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) COVID-19 Persistent SymptomsCompletedNCT04919031Not applicable
- Comparative Analysis of Anti-COVID-19 (Severe Acute Respiratory Syndrome) Humoral and Memory T Cell Responses in Children With Various Degrees of Immunosuppression:CompletedNCT04916847
- Impact of Severe Acute Respiratory Syndrome (SARS-CoV-2/COVID-19) Related Pneumonia on Lung Function and Structure.Status unknownNCT04916834
- Antibody Detection of Vaccine-Induced Secretory EffectsCompletedNCT04895475
- Collection of the Thrombo-VaxCov CohortWithdrawnNCT04889326
- Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort.CompletedNCT04885452
- SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel Following mRNA COVID-19 VaccinationActive, not recruitingNCT04880174Not applicable
- Severity of the New UK SARS-Cov2 Variant in COVID-19 InfectionStatus unknownNCT04863547
- Comparison of Strategies Based on RT-PCR or Antigenic Test for the Screening of SARS-CoV-2 Infection (COVID-19).CompletedNCT04859023Not applicable
- Evaluation of the Effect of Coronavac Vaccine (Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2 Vaccine) on Healthcare Workers' Menstrual PatternsCompletedNCT04854408
- Proxalutamide Treatment for COVID-19 Patients in Intensive Care UnitWithdrawnNCT04853927Phase 3
- Quercetin In The Treatment Of SARS-COV 2CompletedNCT04853199Early Phase 1
- Proxalutamide Treatment for COVID-19 Female OutpatientsWithdrawnNCT04853134Phase 3
- The Effectiveness of Phytotherapy in SARS-COV2(COVID-19)CompletedNCT04851821Phase 1
- RECOVAC - Long Term Efficacy and Safety of COVID-19 (SARS-CoV-2) Vaccination in Kidney Disease PatientsCompletedNCT04841785
- Seroprevalence of SARS-CoV-2 in Unselected Surgical Patients: an Unicentric, Regional StudyCompletedNCT04839913
- A Study to Evaluate the Immunogenicity and Safety of the SARS-CoV-2 mRNA Vaccine CVnCoV in Elderly Adults Compared to Younger Adults for COVID-19WithdrawnNCT04838847Phase 3
- Sisonke (Together): OPEN LABEL TRIAL COVID-19CompletedNCT04838795Phase 3
- COVID-19 Induced Telogen EffluviumStatus unknownNCT04834102
- Longitudinal Follow-up of Patients With Chronic Inflammatory Rheumatisms (CIRs) Vaccinated Against COVID-19 Compared to Patients Refusing VaccinationCompletedNCT04832022
- Study of HEarT DiseAse and ImmuNiTy After COVID-19 in IrelandStatus unknownNCT04823182
- EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19CompletedNCT04822818Phase 3
- Diode Laser 940 nm in Management of Loss of Taste SensationCompletedNCT04821999Not applicable
- Oral Manifestation in Patients With SARS-CoV2 Infection.CompletedNCT04821986
- MIcrovascular Dysfunction in CRitically Ill cOVID-19 PatientsStatus unknownNCT04819802
- COVID-19 in Polish Ice Swimmers.CompletedNCT04817280
- Policy Responses Against the COVID-19 Pandemic in Latin AmericaStatus unknownNCT04816318
- Tenofovir-DF Versus Hydroxychloroquine in the Treatment of Hospitalized Patients With COVID-19 (TEDHICOV)CompletedNCT04812496
- SARS-Cov-2 (COVID-19) Nasal Pharyngeal and Oral Pharyngeal Wash (SNOW) TrialTerminatedNCT04802408Phase 2/3
- Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19Status unknownNCT04802382Phase 3
- Evaluate the Impact, Safety, Tolerability and Immunogenicity of the Coronavac Vaccine in Kidney Transplant RecipientsStatus unknownNCT04801667Phase 4
- Microbiome Therapy in Covid-19 Primary Care SupportSuspendedNCT04793997Not applicable
- Effect of N-acetylcysteine on Oxidative Stress in COVID-19 PatientsCompletedNCT04792021Phase 3
- Initial CT Findings and CO-RADS Stage in COVID-19CompletedNCT04789447
- Ivermectin Reproposing for Mild Stage COVID-19 OutpatientsCompletedNCT04784481Phase 1/2
- Rapid Detection of COVID-19 by Portable and Connected Biosensor : Biological Proof of ConceptCompletedNCT04780334
- Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Disease (COVID-19) in the Oncology Outpatient SettingStatus unknownNCT04779346
- Caracterisation of COVID-19 Patients Hospitalized in Infectious Disease DepartmentStatus unknownNCT04779021
- Intersectoral Platform (SÜP) of the National Pandemic Cohort Network (NAPKON)Status unknownNCT04768998
- Olfactory Training for Olfactory Dysfunction After Coronavirus Disease - 19 (COVID-19)Status unknownNCT04764981Not applicable
- National Cohort Study of Effectiveness and Safety of SARS-CoV-2/COVID-19 Vaccines (ENFORCE)CompletedNCT04760132Phase 4
- Systematic Offer of Nurse-Driven Screening for COVID-19 in Emergency Departments in the Paris Metropolitan Area, DEPIST-COVIDCompletedNCT04756609Not applicable
- Mucolytics in Patients on Invasive Mechanical Ventilation Due to Severe Acute Respiratory Syndrome Coronavirus 2CompletedNCT04755972Not applicable
- Prognosis and Course of COVID-19 Infection in Hospitalised PatientsCompletedNCT04752085
- Safety and Immunogenicity of an Intranasal SARS-CoV-2 Vaccine (BBV154) for COVID-19CompletedNCT04751682Phase 1
- SARS-CoV-2 (COVID-19) Longitudinal Study: Understanding Susceptibility, Transmission and Disease Severity (Legacy Study)Status unknownNCT04750356
- Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Immune Kidney Transplant Study (COVID-19)CompletedNCT04747522
- COVID-19 Contact Study by Antigen Detection TestWithdrawnNCT04745533
- Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19CompletedNCT04745442Phase 2
- A Feasibility Study Using the CoronaCheck Device to Identify Incident Cases of SARS CoV-2 Covid-19CompletedNCT04742712
- '4C' Intervention to Reduce SARS-CoV-2 (Covid-19) TransmissionWithdrawnNCT04739449Not applicable
- Analysing the French COVID-19 Epidemic Using a National SARS-CoV-2 RT-PCR DatabaseStatus unknownNCT04738331
- The Effect of Vitamin D Therapy on Morbidity and Moratlity in Patients With SARS-CoV 2 InfectionCompletedNCT04733625Not applicable
- Efficacy of the Sit to Stand Test in the Decision to Hospitalize a Patient Consulting the Emergency Dept for COVID 19TerminatedNCT04730661Not applicable
- The DAWN Antivirals Trial for Ambulatory COVID-19 PatientsTerminatedNCT04730206Phase 3
- Direct Topical Lung T3 Treatment to Improve Outcome & Sequelae of COVID-19 Acute Respiratory Distress SyndromeWithdrawnNCT04725110Phase 2
- Comparison of Non-invasive Oxygenation Strategies in Patients Admitted for Covid-19 Acute Respiratory Distress SyndromeCompletedNCT04725084
- A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit vs Hologic Panther FusionCompletedNCT04720794Not applicable
- COVID-19: SARS-CoV-2 Detection in Saliva, Oropharyngeal and Nasopharyngeal SpecimensCompletedNCT04715607Not applicable
- Prognostic Value of Flow-mediated Dilation in Hospitalized COVID-19 PatientsStatus unknownNCT04714125
- Fluvoxamine for Adults With Mild to Moderate COVID-19SuspendedNCT04711863Phase 2
- Isavuconazole for the Prevention of COVID-19-associated Pulmonary AspergillosisTerminatedNCT04707703Phase 3
- Michigan Medicine COVID-19 Cohort: Clinical Characteristics, Inflammatory Markers and Outcomes of Patients Hospitalized for COVID-19CompletedNCT04706533
- A Clinical Trial of COVAC-2 in Healthy AdultsCompletedNCT04702178Phase 1
- Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenanCompletedNCT04701710Phase 1/2
- COVID-19 Infection and Fetal-neonatal OutcomesStatus unknownNCT04699578
- COVID-19 Sero-prevalence Health Care Workers KinshasaCompletedNCT04699058
- Immunogenicity, Efficacy and Safety of QazCovid-in® COVID-19 VaccineCompletedNCT04691908Phase 3
- Use of Hypochlorous Acid as Prophylaxis in Health Personnel at High Risk of Infection by SARS-CoV 2 (COVID19)WithdrawnNCT04684550Phase 2/3
- Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care WorkersCompletedNCT04681001Not applicable
- Evaluation of Sedation in COVID-19 ARDSCompletedNCT04667936
- Infection Control for Severe Acute Respiratory Syndrome Coronavirus 2CompletedNCT04665960
- Surgery and Lung Ultrasound in COVID-19 InfectionStatus unknownNCT04661631
- Adolescents With COVID-19/MIS-C at HCFMUSPStatus unknownNCT04659486Not applicable
- Glenzocimab in SARS-Cov-2 Acute Respiratory DistrEss syNdrome Related to COVID-19CompletedNCT04659109Phase 2
- A Phase III Clinical Trial of the Immunogenicity and Safety of the Gam-COVID-Vac Vaccine Against COVID-19 in the UAEStatus unknownNCT04656613Phase 3
- Seroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic DiseasesCompletedNCT04655612
- RT-PCR Database Analysis for COVID-19 Infections and Re-infectionStatus unknownNCT04653844
- Efficacy and Safety of Ozonised Oil (HOO) in COVID-19 PatientsWithdrawnNCT04651387Not applicable
- Differences in Exhaled Breath by Using Ion Mobility Spectrometry (IMS) in Subjects Tested for SARS-CoV-2 Infection (COVID-19 Disease)CompletedNCT04649931
- Short and Medium-term Effects of Pulmonary Rehabilitation in Mild to Critical Post-acute COVID-19CompletedNCT04649918